Danaher Corporation $DHR Shares Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. grew its position in Danaher Corporation (NYSE:DHR) by 8.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,919 shares of the conglomerate’s stock after purchasing an additional 2,926 shares during the quarter. Assenagon Asset Management S.A.’s holdings in Danaher were worth $7,379,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in DHR. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher in the 4th quarter worth $26,000. Hilton Head Capital Partners LLC acquired a new position in Danaher during the 4th quarter valued at about $27,000. Clal Insurance Enterprises Holdings Ltd raised its stake in Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after buying an additional 53 shares during the last quarter. JPL Wealth Management LLC purchased a new stake in Danaher in the third quarter valued at about $25,000. Finally, WFA of San Diego LLC acquired a new stake in Danaher in the second quarter worth about $26,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Down 0.3%

Danaher stock opened at $195.67 on Monday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a market capitalization of $138.49 billion, a price-to-earnings ratio of 37.85, a price-to-earnings-growth ratio of 2.50 and a beta of 0.81. The stock has a 50-day moving average price of $178.81 and a 200 day moving average price of $201.53.

Danaher (NYSE:DHR) last issued its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the prior year, the firm earned $1.88 earnings per share. Danaher’s revenue for the quarter was up 3.7% on a year-over-year basis. Sell-side analysts anticipate that Danaher Corporation will post 8.44 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.

Analyst Ratings Changes

Several research firms have recently issued reports on DHR. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a report on Friday, April 17th. Wall Street Zen cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Wells Fargo & Company dropped their target price on shares of Danaher from $240.00 to $212.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 22nd. HSBC cut their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Finally, Evercore lifted their price objective on shares of Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 21st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.